SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $210,000 | -28.6% | 4,944 | -25.6% | 0.06% | -17.1% |
Q3 2021 | $294,000 | -30.5% | 6,644 | -10.7% | 0.07% | -27.8% |
Q2 2021 | $423,000 | -26.4% | 7,443 | -3.2% | 0.10% | -30.7% |
Q1 2021 | $575,000 | -34.3% | 7,688 | -24.0% | 0.14% | -39.1% |
Q4 2020 | $875,000 | +32.0% | 10,117 | -6.7% | 0.23% | +17.3% |
Q3 2020 | $663,000 | +55.6% | 10,840 | +5.8% | 0.20% | +41.0% |
Q2 2020 | $426,000 | +86.0% | 10,247 | +28.8% | 0.14% | +61.6% |
Q1 2020 | $229,000 | -56.5% | 7,957 | +9.2% | 0.09% | -53.5% |
Q4 2019 | $526,000 | -40.9% | 7,289 | +14.9% | 0.18% | -35.3% |
Q3 2019 | $890,000 | -23.4% | 6,344 | 0.0% | 0.29% | -22.1% |
Q2 2019 | $1,162,000 | +17.6% | 6,344 | +2.1% | 0.37% | +30.6% |
Q1 2019 | $988,000 | +79.0% | 6,214 | +7.9% | 0.28% | +33.8% |
Q4 2018 | $552,000 | -18.7% | 5,759 | +19.7% | 0.21% | -9.5% |
Q3 2018 | $679,000 | -18.3% | 4,810 | -9.4% | 0.23% | -27.5% |
Q2 2018 | $831,000 | -2.8% | 5,310 | 0.0% | 0.32% | -5.3% |
Q1 2018 | $855,000 | 0.0% | 5,310 | +2.3% | 0.34% | -3.7% |
Q4 2017 | $855,000 | +162.3% | 5,190 | -0.7% | 0.35% | +172.1% |
Q3 2017 | $326,000 | -22.7% | 5,226 | -1.3% | 0.13% | -22.3% |
Q2 2017 | $422,000 | +45.0% | 5,296 | +29.2% | 0.17% | +38.3% |
Q1 2017 | $291,000 | – | 4,100 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |